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S63ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111conditions. These results demonstrate the presence of iPLA2 in lung
mitochondria and support the hypothesis that the activation of
mitochondrial phospholipases by mild oxidative stress can provide
free fatty acids as cycling substrates for UCP2. However, attenuation of
ROS production by UCP2 is not signiﬁcant.
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We have studied the quinone structural features that confer
modulatory properties on the mitochondrial permeability transition
pore (PTP). Reduced derivatives of ubiquinone (Ub) 0 with acetoxy or
methoxy substitutions of the carbonyl groups became ineffective at
PTP inhibition. Consistent with a key role of the Ub0 oxidation-
reduction state for its interactions with the PTP, DTT prevented the
inhibitory effects on the pore when added before but not after Ub0. Of
note, the addition of DTT after Ub0 prevented the toxic effects of Ub0
on respiration. The combination of Ub0 and DTT thus allowed
inhibition of the PTP without mitochondrial toxicity, which in the
absence of DTT reveals itself with a bell-shaped curve where the Ub0-
dependent increase of mitochondrial Ca2+ retention capacity (a
measure of PTP inhibition) is superceded by a decrease as the Ub0
concentration is raised above about 50 μM. The PTP inhibitory effects
of decylUb were instead unaffected by reducing agents, and Ub0 and
decylUb displayed additive effects on PTP inhibition, indicating that
they act at different inhibitory sites on the PTP.
doi:10.1016/j.bbabio.2008.05.247
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Synthesized in the Skulachev's laboratory new type of mitochon-
dria-targeted antioxidants — plastoquinone derivatives (SkQs) were
investigated. The aim of our study was to estimate of antioxidant
properties of the SkQ family members plastoquinonyl decyltriphe-
nylphosphonium (SkQ1) and plastoquinonyl decylrhodamin 19
(SkQR1), a ﬂuorescent derivative. These compounds combined with
a positively-charged penetrating cations were selectively targeted to
mitochondria, being accumulated inside, and can be reduced by the
respiratory chain. Using confocal microscope we observed that SkQR1
was accumulated bymitochondria. Uncoupling action of FCCP, leading
to mitochondrial depolarization, prevented the SkQR1 staining. In
human cell cultures HeLa and K562 very low concentrations
(nanomolar) of antioxidants were found to prevent ROS-induced
apoptosis and necrosis. Oxidative stress initiated by addition of small
amount H2O2 to living cells, caused secondary generation of
endogenous ROS and lowered the level of reduced glutathione.SkQ1 and SkQR1 prevented oxidative damage as well as glutathione
oxidation, C1/2 being around 2nM and 0.5 nM respectively. It is
concluded that cationic plastoquinone derivatives are rechargeable,
mitochondria-targeted antioxidants of very high efﬁciency.
doi:10.1016/j.bbabio.2008.05.248
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Our aimwas to analyse the effects of VP on the production of ROS by
lymphocytes and determine the possible mitochondrial sources of
these ROS. Twelve women affected by VP and twelve control healthy
women participated in the study. H2O2 production was measured
using 2,7-dichloroﬂuorescin-diacetate as indicator in basal conditions
and after stimulation with PMA. In addition three treatments with
allopurinol, rotenone or myxothiazol were performed in PMA-
stimulated lymphocytes. No differences were observed between
porphyric and control women in the basal production of H2O2. The
stimulation with PMA increased H2O2 production in both groups but
lymphocytes from porphyric women produced higher levels of H2O2
than controls. The treatments with allopurinol and rotenone did not
modify H2O2 production but after treatment with myxothiazol H2O2
production decreased back to basal levels in both groups. In
conclusion, lymphocytes from women affected by VP produce the
same amount of H2O2 in basal conditions than control women, but
after stimulation lymphocytes from porphyric women produce higher
levels of H2O2. This increased H2O2 production is due to an impaired
function of the mitochondrial respiratory chain rather than to other
ROS sources such as xanthine oxidase.
doi:10.1016/j.bbabio.2008.05.249
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Camptothecin (CPT), a topoisomerase I inhibitor, is used for treat-
ment of certain types of malignancies. Uncoupling protein 2 (UcP2) is
proposed to protect cardiomyocytes against oxidative stress. Modula-
tion of UcP2 level appears important because the protein increases in
failing human heart. p38MAPK belongs to a group of protein serine/
threonine kinases that become activated in response to extracellular
stimuli and mediate signal transduction in cell growth, differentiation
and apoptosis. We found that CPT treatment induces UcP2 expression
on both mRNA and protein level in cardiomyocytes. This induction is
accompanied by short-term increase in production of ROS (b1 h)
preceded by activation of p38MAPK (b30 min). Activation of p38MAPK
by CPT was comparable to anisomycin, a protein synthesis inhibitor
that activates stress-related MAPKs, namely p38MAPK in mammalian
cells. Pretreatment of cardiomyocytes with p38MAPK inhibitor,
SB203580, blocked activation of p38MAPK by both compounds and
abolished the camptothecin-mediated UcP2 induction. Our results
S64 ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111suggest that activation of p38MAPK-regulated signaling cascade leads
to increased expression of UcP2 in cardiomyocytes as seen on protein
as well as mRNA level offering a protective mechanism against CPT-
related apoptosis.
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Oxidative damage of mitochondrial compartments contribute to a
range of degenerative diseases. Here protective effect of quinones and
their derivatives on mitochondrial proteins and lipids under oxidative
stress was analysed. The most effective quinone analogues appear to
be conjugates of lipophilic cations (“Skulachev cations”, by D. Green)
with ubiquinone (Murphy et al., 2007) or plastoquinone (Skulachev et
al., 2008, in press), so called “mitochondrially targeted antioxidants”
(MTAO). MTAO effectively inhibit lipid peroxidation and protect
membrane cardiolipin from oxidation. Using dihydroethidium and
Amplex Red as a probes for ROS detection, we found that MTAO
effectively suppress ROS production from different sites of the
mitochondrial respiratory chain. In succinate-energised mitochondria
there is a lag-period for the MTAO effect, but not in pyruvate/malate-
energised mitochondria. When mitochondria isolated from the heart
of a mouse strain mutated on mitochondrial DNA polymerase PolgA
(Trifunovic et al., 2004) were used, we found that the mitochondria of
PolgA mice did not produce more ROS than wild type, but the
inhibitory effect of MTAO was stronger and more pronounced. Taken
together, these data provided evidence that MTAO could be useful for
treatment of genetic disorders, manifested degenerative diseases and
aging complications.
doi:10.1016/j.bbabio.2008.05.251
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Nerolidol is a naturally occurring sesquiterpenol found in the
essential oils of many types of plants and ﬂowers. The aim of this studywas to assess the impact of a racemic mixture of nerolidol on the
oxidative phosphorylation of mitochondria isolated from rat liver. We
examined the effect of nerolidol on respiratory indexes, membrane
potential and opening of the mitochondrial permeability transition
pore, all the assays were performed with 0.5 mg mitochondrial
protein/mL. Our results showed a complex array of effects on liver
mitochondrial bioenergetics. With nerolidol (1.2 µM) we observed an
increase in state 4 respiration rate (170±5.4% of control), a depression
in state 3 (64±9.7% of control) and a decreased uncoupled respiration
rate (53±10,1% of control). Mitochondrial membrane potential was
decreased (1.2 µM; 27±6.4% of control) by nerolidol in a concentration
manner. ATP synthase was not signiﬁcantly affected in the concentra-
tion range of study (0–1.2 µM). Nerolidol seems to increase the
mitochondrial ability to accumulate calcium by decreasing the
susceptibility of mitochondria to the opening of the transition pore.
Nerolidol (0.2 µM) protect against tert-buthylhydroperoxide mito-
chondrial membrane lipid peroxidation, however H2O2 produced by
mitochondria with blocked respiratory complexes was increased by
nerolidol. From our data it is concluded that concentrations of
nerolidol lower than 0.4 µM don't affect mitochondrial bioenergetics
and could probably used to prevent the deleterious effect of some
oxidative events occurring in mitochondria.
doi:10.1016/j.bbabio.2008.05.252
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Mitochondrial uncoupling proteins (UCPs) are inner mitochondrial
membrane proteins that dissipate the mitochondrial proton gradient
by transporting H+ across the inner membrane, thereby stabilizing the
inner mitochondrial membrane potential (ΔΨm) and reducing the
formation of ROS (Nicholls 1977; Stuart et al., 2001). Previous studies
have shown that UCP2 protects neurons against oxidative stress and
cerebral stroke (Bechmann et al., 2002; Mattiasson et al., 2003).
However, a recent study reported opposite effects of UCP2 by showing
that ablation of UCP2 reduced stroke infarct area in the brain (de Bilbao
et al., 2004). The objectives of this study are to clarify the effects of
UCP2 on ischemic brain damage and to explore whether deletion of
UCP2 gene alters expression proﬁle of other genes after transient
cerebral ischemia. Middle cerebral artery occlusion (MCAO) of 1 h
durationwas induced in UCP2 knockout (UCP-KO) andwild typemice.
Animals were sacriﬁced 24 h after reperfusion. The infarct volumewas
depicted using the TTC staining. The integrity of the circle of Willis of
UCP2-KO and wild type mice was examined by carbon black injection.
Transcript levels of 84 genes in the cortical ischemic penumbra area
were detected using a Mouse Stress Toxicity PCR array (Super Array).
The results were normalized against housekeeping genes Hprt1 and
beta actin. The results showed that deletion of UCP2 gene signiﬁcantly
increased infarct size and there was no obvious vascular abnormalities
observed. The SuperArray study demonstrated that knocking out UCP2
gene signiﬁcantly suppressedDNA repair gene cyclin G1 (van Lookeren
Campagne and Gill 1998), antioxidative gene GSTM1 (McBride et al.,
2005) and neuroprotective gene MDM2 (Saito et al., 2005). These
resultswere further veriﬁed by immunohistochemistry. It is concluded
that knocking out of UCP2 gene exacerbates neuronal death after
cerebral ischemia and reperfusion and that deletion of UCP2 gene
suppresses genes associated with cell survival.
doi:10.1016/j.bbabio.2008.05.253
